1. THE IMPACT OF DEGRADATION INHIBITOR OF GLUCAGON LIKE POLYPEPTIDE 1 ON BODY WEIGHT AND BETA-CELL FUNCTION IN OBESE WOMEN WITH POLYCYSTIC OVARIAN SYNDROMESimona Ferjan, 2018, doktorsko delo/naloga Ključne besede: PCOS, prediabetes, GLP-1 response, DPP-4 inhibitor, sitagliptin, weight maintenance, GLP-1 receptor agonist, liraglutide
Celotno besedilo (datoteka, 1,64 MB) |
|
3. The pharmacological properties and therapeutic use of apomorphineSamo Ribarič, 2012, pregledni znanstveni članek Ključne besede: apomorphine, Alzheimer’s disease, dopamine agonist, erectile dysfunction, Parkinson’s disease, impotence, pharmacology, drug therapy, diet therapy
Celotno besedilo (datoteka, 577,08 KB) Gradivo ima več datotek! Več... |
4. Synthesis of conformationally constrained D-Glu-meso-DAP analogs as innate immune agonistsSamo Guzelj, Žiga Jakopin, 2020, izvirni znanstveni članek Ključne besede: NOD1 agonist, constrained meso-DAP mimetics, NOD1 activation, innate immune agonist, bioisosteric replacement, rigidization
Celotno besedilo (datoteka, 1,65 MB) Gradivo ima več datotek! Več... |
5. The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodiesTijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan, 2022, izvirni znanstveni članek Ključne besede: B-cell leukemia and lymphoma, chronic lymphocytic leukemia, prostaglandin EP4 receptor, selective EP4 receptor agonist, monoclonal antibodies, synergistic effects
Celotno besedilo (datoteka, 1,90 MB) Gradivo ima več datotek! Več... |
6. Precocious puberty in a girl with 3-methylglutaconic aciduria type 1 (3-MGA-I) due to a novel AUH gene mutationNeli Bizjak, Mojca Žerjav-Tanšek, Magdalena Avbelj Stefanija, Barbka Repič-Lampret, Ajda Mezek, Ana Drole Torkar, Tadej Battelino, Urh Grošelj, 2020, drugi znanstveni članki Ključne besede: 3-MGA-I, 3-methylglutaconic aciduria type 1, precocious puberty, AUH gene, GnRH agonist, triptorelin
Celotno besedilo (datoteka, 497,33 KB) Gradivo ima več datotek! Več... |
7. Nucleotide-binding oligomerization domain 1/Toll-like receptor 4 co-engagement promotes non-specific immune response against K562 cancer cellsSamo Guzelj, Žiga Jakopin, 2022, izvirni znanstveni članek Ključne besede: NOD1 agonist, TLR4 agonist, LPS, synergy, cytolytic activity, PBMC, NK cells, K562
Celotno besedilo (datoteka, 1,74 MB) Gradivo ima več datotek! Več... |
|
9. Sinteza pirolidinskih, piperidinskih in piperazinskih derivatov 6-(trifluorometil)izoksazolo[5,4-d]pirimidina kot agonistov Tollu podobnega receptorja 7Benjamin Smajić, 2022, magistrsko delo/naloga Ključne besede: imunski sistem, Tollu podobni receptor, TLR7, agonist, pirimidin
Celotno besedilo (datoteka, 2,10 MB) |
10. Covalently conjugated NOD2/TLR7 agonists are potent and versatile immune potentiatorsSamo Guzelj, Matjaž Weiss, Bram Slütter, Ruža Frkanec, Žiga Jakopin, 2022, izvirni znanstveni članek Ključne besede: immunostimulatory activity, vaccines, immune responses, pattern recognition receptors, synthesis of NOD2 agonist, Toll-like receptor 7
Celotno besedilo (datoteka, 4,87 MB) Gradivo ima več datotek! Več... |
